<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Fritsch, G.</title>
    <link>http://repub.eur.nl/res/aut/6802/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro (Article)</title>
      <link>http://repub.eur.nl/res/pub/9135/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>Although erythropoietin (Epo) is essential for the production of mature
          red blood cells, the cooperation with other factors is required for a
          proper balance between progenitor proliferation and differentiation. In
          avian erythroid progenitors, steroid hormones cooperate with tyrosine
          kinase receptors to induce renewal of erythroid progenitors. We examined
          the role of corticosteroids in the in vitro expansion of primary human
          erythroid cells in liquid cultures and colony assays. Dexamethasone (Dex),
          a synthetic glucocorticoid hormone, cooperated with Epo and stem cell
          factor to induce erythroid progenitors to undergo 15 to 22 cell divisions,
          corresponding to a 10(5)- to 10(6)-fold amplification of erythroid cells.
          Dex acted directly on erythroid progenitors and maintained the
          colony-forming capacity of the progenitor cells expanded in liquid
          cultures. The hormone delayed terminal differentiation into erythrocytes,
          which was assayed by morphology, hemoglobin accumulation, and the
          expression of genes characteristic for immature cells. Sustained
          proliferation of erythroid progenitors could be induced equally well from
          purified erythroid burst-forming units (BFU-E), from CD34(+) blast cells,
          and from bone marrow depleted from CD34(+) cells.</description>
    </item>
  </channel>
</rss>